【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Biologics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Advancements in biomedical science
3.1.1.2 Rise in biologics contract manufacturing services
3.1.1.3 Several drugs going off patents
3.1.1.4 Commercial success of biologics
3.1.2 Market Restraint Analysis
3.1.2.1 Pharmacokinetics challenges associated with biologics
3.1.2.2 Rising control & cost for accessing biologics
3.1.2.3 Development of biosimilars
3.2 Penetration & Growth Prospect Mapping for Product, 2016
3.3 Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Biologics: Pipeline Analysis
Chapter 4 Biologics Market: Source Estimates & Trend Analysis
4.1 Global Biologics Market: Source Movement Analysis
4.2 Microbial Source
4.2.1 Global microbial source market, 2014 – 2025 (USD Billion)
4.3 Mammalian Source
4.3.1 Global mammalian source market, 2014 – 2025 (USD Billion)
4.4 Others
4.4.1 Global other source market, 2014 – 2025 (USD Billion)
Chapter 5 Biologics Market: Product Estimates & Trend Analysis
5.1 Global Biologics Market: Product Movement Analysis
5.2 Monoclonal Antibodies
5.2.1 Global monoclonal antibodies market, 2014 – 2025 (USD Billion)
5.2.2 Monoclonal antibodies by application
5.2.2.1 Diagnostic monoclonal antibodies
5.2.2.1.1 Diagnostic MABs market, 2014 – 2025 (USD Billion)
5.2.2.1.2 Diagnostic MABs for biochemical analysis
5.2.2.1.3 Diagnostic MABs for imaging
5.2.2.2 Therapeutic MABs
5.2.2.2.1 Therapeutic MABs market, 2014 – 2025 (USD Billion)
5.2.2.2.2 Direct MABs
5.2.2.2.3 Targeting MABs
5.2.2.3 Protein purification MABs
5.2.2.3.1 Protein purification MABs market, 2014 – 2025 (USD Billion)
5.2.2.4 Other MABs
5.2.2.4.1 Other MABs market, 2014 – 2025 (USD Billion)
5.2.3 Monoclonal antibodies by type
5.2.3.1 Murine MABs
5.2.3.1.1 Murine MABs market, 2014 – 2025 (USD Billion)
5.2.3.2 Chimeric MABs
5.2.3.2.1 Chimeric MABs market, 2014 – 2025 (USD Billion)
5.2.3.3 Humanized MABs
5.2.3.3.1 Humanized MABs market, 2014 – 2025 (USD Billion)
5.2.3.4 Human MABs
5.2.3.4.1 Human MABs market, 2014 – 2025 (USD Billion)
5.2.3.5 Other MABs
5.2.3.5.1 Other MABs market, 2014 – 2025 (USD Billion)
5.3 Vaccines
5.3.1 Global vaccines market, 2014 – 2025 (USD Billion)
5.4 Recombinant Proteins
5.4.1 Global recombinant proteins market, 2014 – 2025 (USD Billion)
5.5 Antisense, RNAi & Molecular Therapy
5.5.1 Global antisense, RNAi & molecular therapy market, 2014 – 2025 (USD Billion)
5.6 Others
5.6.1 Global other product market, 2014 – 2025 (USD Billion)
Chapter 6 Biologics Market: Manufacturing Estimates & Trend Analysis
6.1 Global Biologics Market: Manufacturing Movement Analysis
6.2 Outsourced
6.2.1 Global outsourced market, 2014 – 2025 (USD Billion)
6.3 In-house
6.3.1 Global in-house market, 2014 – 2025 (USD Billion)
Chapter 7 Biologics Market: Disease Category Estimates & Trend Analysis
7.1 Global Biologics Market: Disease Category Movement Analysis
7.2 Oncology
7.2.1 Global oncology market, 2014 – 2025 (USD Billion)
7.2.2 MABs market for oncology
7.2.2.1 Global MABs market for oncology, 2014 – 2025 (USD Billion)
7.2.3 Vaccines market for oncology
7.2.3.1 Global vaccines market for oncology, 2014 – 2025 (USD Billion)
7.2.4 Recombinant proteins market for oncology
7.2.4.1 Global recombinant proteins market for oncology, 2014 – 2025 (USD Billion)
7.2.5 Antisense, RNAi, & molecular therapy market for oncology
7.2.5.1 Global antisense, RNAi, & molecular therapy market for oncology, 2014 – 2025 (USD Billion)
7.2.6 Other products market for oncology
7.2.6.1 Global products market for oncology, 2014 – 2025 (USD Billion)
7.3 Infectious Disease
7.3.1 Global infectious disease market, 2014 – 2025 (USD Billion)
7.3.2 Vaccines market for infectious disease
7.3.2.1 Global vaccines market for infectious disease, 2014 – 2025 (USD Billion)
7.3.3 MABs market for infectious disease
7.3.3.1 Global MABs market for infectious disease, 2014 – 2025 (USD Billion)
7.3.4 Antisense, RNAi, & molecular therapy market for infectious disease
7.3.4.1 Global antisense, RNAi, & molecular therapy market for infectious disease, 2014 – 2025 (USD Billion)
7.3.5 Recombinant proteins market for infectious disease
7.3.5.1 Global recombinant proteins market for infectious disease, 2014 – 2025 (USD Billion)
7.3.6 Other products market for infectious disease
7.3.6.1 Global products market for infectious disease, 2014 – 2025 (USD Billion)
7.4 Immunological Disorders
7.4.1 Global immunological disorders market, 2014 – 2025 (USD Billion)
7.5 Cardiovascular disorders
7.5.1 Global cardiovascular disorders market, 2014 – 2025 (USD Billion)
7.6 Hematologic Disorders
7.6.1 Global hematologic disorders market, 2014 – 2025 (USD Billion)
7.7 Others
7.7.1 Global other indications market, 2014 – 2025 (USD Billion)
Chapter 8 Biologics Market: Regional Estimates & Trend Analysis, by Source, Product, Manufacturing, & Disease Category
8.1 Biologics Market Share By Region, 2015 & 2025
8.2 North America
8.2.1 North America biologics market, 2014 – 2025 (USD Billion)
8.2.2 U.S.
8.2.2.1 U.S. biologics market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada biologics market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe biologics market, 2014 – 2025 (USD Billion)
8.3.2 Germany
8.3.2.1 Germany biologics market, 2014 – 2025 (USD Billion)
8.3.3 UK
8.3.3.1 UK biologics market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific biologics market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan biologics market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China biologics market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America biologics market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil biologics market, 2014 – 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa biologics market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa biologics market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Samsung BioLogics
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Amgen
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Novo Nordisk A/S
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 AbbVie Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Sanofi
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Johnson & Johnson Services, Inc
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Pfizer Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Merck & Co., Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.9 GSK group of companies
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Celltrion
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Precision Biologics, Inc.
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Merck KGaA
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Eli Lilly and Company
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 Novartis AG
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 Bayer AG
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 F. Hoffmann-La Roche Ltd
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 AstraZeneca
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
【レポート販売概要】
■ タイトル：生物製剤の世界市場分析：由来別（微生物、哺乳類）、製品別（モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi、分子治療）、病気の種類別、製造法別、セグメント予測、2014-2025■ 英文：Biologics Market Analysis By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy), By Disease Category, By Manufacturing, And Segment Forecasts, 2014-2025
■ 発行日：2017年3月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707122
■ 調査対象地域：グローバル
- 産業用ボイラーの世界市場2017-2021About Industrial Boilers A boiler is typically a closed vessel and has water stored inside it. In this heating system, a furnace is required to heat the boiler. Fuels such as coal are used to generate the heat. Subsequently, the heated air comes in contact with the vessel and convection takes place, heating the water inside the vessel. The heated water eventually produces steam. Technavio’s analys …
- クラウド実現技術の世界市場：仮想化、オートメーション、サービス指向アーキテクチャ（SOA）About Cloud-enabling Technologies Cloud computing came into existence through advancement in the field of hardware, software, and networking. The evolution of cloud computing is made possible through technologies such as virtualization, automated computing, and service-oriented architecture (SOA). These technologies are commonly termed as cloud-enabling technologies. Cloud computing provides an op …
- ICT調達動向：金融産業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which financial market institutions select their IT providers as well as the roles which have influence while making IT purchasing decisions. What is the current market landscape and what is changing? Financial market institutions are keen to deploy their technologies on-site as they have to adhere to strict compliance regulations relating t …
- 世界のドキュメント・キャプチャ・ソフトウェア市場：Global Document Capture Software Market 2014-2018TechNavio's analysts forecast the Global Document Capture Software market to grow at a CAGR of 9.65 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for regulatory compliance. The Global Document Capture Software market has also been witnessing the emergence of SaaS-based document capture software. However, the issues related to scalability, …
- 世界の眼科医薬品市場予測：網膜疾患/アレルギー性炎症/緑内障/眼球乾燥症治療薬Ophthalmic drugs – new study showing you trends, R&D progress, and predicted revenues Where is the ophthalmic drugs market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 337-page report provides 198 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospect …
- 世界のセラミックコンデンサー市場2015The Global Ceramic Capacitors Industry Report 2015 is a professional and in-depth study on the current state of the Ceramic Capacitors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ceramic Capacitors market analysis is provided for the international markets including development trends, competit …
- 世界主要国における前立腺酸性フォスファターゼ（PAP）検査市場2015This report contains 242 pages, 11 tables and presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.The cancer diagnostics market is on …
- AI（人工知能）プラットフォームの世界市場予測（～2022年）：ツール、サービスThe global AI platform market is expected to grow from USD 2.61 Billion in 2017 to USD 9.88 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 30.5%. The major driving factors for the market are a proliferation in data generation, increasing demand for AI-based solutions, increasing operational efficiency and reduced cost, and growing need to enhance customer experience. In the tools segm …
- 北米の鉄道車両市場ABSTRACTAbout Rolling Stock Rolling stock refers to wheeled railway vehicles that move on tracks; for example, locomotives, passenger rail vehicles, and freight wagons. It includes both self-propelled and externally propelled vehicles. Technavio’s analysts forecast the rolling stock market in North America to grow at a CAGR of 4.07% during the period 2017-2021. [Covered in this report] The report …
- LiDARの世界市場予測（～2023年）“The LiDAR market is estimated to grow at a CAGR of 17.2% between 2018 and 2023” The overall LiDAR market is expected to reach USD 1,809.5 million by 2023 from USD 819.1 million by 2018, at a CAGR of 17.2% between 2018 and 2023. The increasing use of drones equipped with LiDAR for greater accuracy in surveying applications and the introduction of technologically enhanced LiDAR are the key factors …
- トップ10バイオプロセス技術の世界市場予測（～2021）：細胞培養、細胞増殖、細胞数、細胞株開発、フローサイトメトリー、シングルユースバイオプロセス、バイオロジクス安全性試験、タンジェント流ろ過、ウイルスろ過、地域別 分析The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virus filtration, biologics safety testing, pyrogen testing, and tangential …
- 北米のキャップ及びクロージャー市場2016-2020About Caps and Closures Caps and closures are essential elements in the overall packaging of products, enhancing both the aesthetics and functionality of the products. They protect packaged products such as food and beverages from spoilage, dust, pollutants, and evaporation. They keep the contents fresh and make handling convenient. Today, caps and closures are also used for product differentiatio …
- 熱流量計の世界市場2015-2019About Thermal Flowmeters Thermal flowmeters are used to measure the flow of gas. They discharge heat into the flow stream and measure the rate of dissipation of heat using temperature-sensitive sensors. This method yields optimum results with gas flows. There are two different methods used to measure the rate at which heat is dissipated. However, most of the thermal flowmeters discharge heat into …
- 世界の菓子類市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global confectionery market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global confectionery market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the gl …
- Greeceのニッケル鉱と濃縮物市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Greece and its perspectives on the global market for Nickel ores and concentrates. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Nickel ores and concentrates export/import operations in Greece. The 2002-2012 …
